Literature DB >> 28493420

Comment on: "Comprehensive first-line magnetic resonance imaging in hypertension: experience from a single-center tertiary referral clinic".

Mustafa Sahin1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28493420      PMCID: PMC8030804          DOI: 10.1111/jch.13027

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  4 in total

Review 1.  Resistant hypertension and hyperaldosteronism.

Authors:  Carolina C Gonzaga; David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

Review 2.  Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension.

Authors:  George Piaditis; Athina Markou; Labrini Papanastasiou; Ioannis I Androulakis; Gregory Kaltsas
Journal:  Eur J Endocrinol       Date:  2014-12-23       Impact factor: 6.664

3.  Comprehensive First-Line Magnetic Resonance Imaging in Hypertension: Experience From a Single-Center Tertiary Referral Clinic.

Authors:  Amy E Burchell; Jonathan C L Rodrigues; Max Charalambos; Laura E K Ratcliffe; Emma C Hart; Julian F R Paton; Andreas Baumbach; Nathan E Manghat; Angus K Nightingale
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-19       Impact factor: 3.738

4.  Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.

Authors:  Elena A B Azizan; Hanne Poulsen; Petronel Tuluc; Junhua Zhou; Michael V Clausen; Andreas Lieb; Carmela Maniero; Sumedha Garg; Elena G Bochukova; Wanfeng Zhao; Lalarukh Haris Shaikh; Cheryl A Brighton; Ada E D Teo; Anthony P Davenport; Tanja Dekkers; Bas Tops; Benno Küsters; Jiri Ceral; Giles S H Yeo; Sudeshna Guha Neogi; Ian McFarlane; Nitzan Rosenfeld; Francesco Marass; James Hadfield; Wojciech Margas; Kanchan Chaggar; Miroslav Solar; Jaap Deinum; Annette C Dolphin; I Sadaf Farooqi; Joerg Striessnig; Poul Nissen; Morris J Brown
Journal:  Nat Genet       Date:  2013-08-04       Impact factor: 38.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.